Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1999-09-07
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 514343, 546193, 5462681, 5462764, C07D40112, A61K 3155
Patent
active
059487933
ABSTRACT:
Novel heterocyclic ether compounds of the formula: ##STR1## wherein n, *, R.sup.1, R.sup.2, R.sup.3 and y are specifically defined, or pharmaceutically acceptable salts or prodrugs thereof, which are useful in selectively controlling neurotransmitter release; therapeutically-effective pharmaceutical compositions of these compounds; and use of said compositions to selectively control neurotransmitter release in mammals.
REFERENCES:
patent: 4592866 (1986-06-01), Cale, Jr.
patent: 4643995 (1987-02-01), Engel et al.
patent: 4705853 (1987-11-01), Cale
patent: 4929625 (1990-05-01), Cliffe et al.
patent: 4946836 (1990-08-01), Engel et al.
patent: 4956359 (1990-09-01), Taylor, Jr. et al.
patent: 5037841 (1991-08-01), Schoehe et al.
patent: 5169855 (1992-12-01), Cain et al.
K. Tomioka et al., Stereoselective Reactions XIX. Asymmetric Dihydroxylation of Olefins by Employing Osmium Tetroxide-Chiral Amine Complexes, Chem. Pharm. Bull., 1990, 38:2133-5.
Sullivan, et al. (.+-.)-Epibatidine Elicits a Diversity of In Vitro and In Vivo Effects Mediated by Nicotinic Acetylcholine Receptors,Journ of Pharm and Experimental Therapeutics vol. 271 No. 2 624-631.
Badio, et al., Antinociceptice Effects of the Aklaloid Epibatidine: Further Studies on Involvement of Nicotine Receptors, Drug Development Research 36:46-59 (1995).
Sullivan, et al., Epibatidine: Pharmacological Properties of a Novel Nicotinic Acetylcholine Receptor Agoists and Analgesic Agent, CNS Drug Reviews vol. 2. No. 1 pp. 21-39.
Burger, Medicinal Chemistry, Third Edition Part I.
Sullivan. The Organic Chemistry of Drug Design and Drug Action; pp. 19-21.
Abreo Melwyn A.
Garvey David S.
Gunn David E.
Holladay Mark W.
Lin Nan-Horng
Abbott Laboratories
Browder Monte R.
Janssen Jerry F.
Rao Deepak R.
Raymond Richard L.
LandOfFree
3-pyridyloxymethyl heterocyclic ether compounds useful in contro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-pyridyloxymethyl heterocyclic ether compounds useful in contro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-pyridyloxymethyl heterocyclic ether compounds useful in contro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804807